Patents by Inventor Pedro Alzari

Pedro Alzari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Publication number: 20060018873
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Application
    Filed: June 28, 2005
    Publication date: January 26, 2006
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • PknB kinase and pstP phosphatase and methods of identifying inhibitory substances
    Publication number: 20060019324
    Abstract: The present invention relates to a pknB kinase and a pstP phosphatase as well as their use for identifying antibacterial substances.
    Type: Application
    Filed: August 3, 2005
    Publication date: January 26, 2006
    Applicant: INSTITUT PASTEUR
    Inventors: Pedro Alzari, Brigitte Boitel, Andrea Villarino, Pablo Fernandez, Stewart Cole
  • Crystallographic structure of TcPRACA and uses therefor
    Publication number: 20050250195
    Abstract: The present invention provides the crystal structure of the Trypanosoma cruzi PRACA proline racemase. Methods of modelling drugs that treat or prevent infection by T. cruzi are also provided, as are the drugs that are identified.
    Type: Application
    Filed: May 26, 2004
    Publication date: November 10, 2005
    Inventors: Paola Minoprio, Pedro Alzari, Alejandro Buschiazzo, Christophe Gregoire, Armand Berneman, Wim Degrave
  • Peptides of IL-2 and derivatives thereof
    Patent number: 6929791
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Grant
    Filed: February 6, 2001
    Date of Patent: August 16, 2005
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Patent number: 6825334
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Grant
    Filed: March 1, 2001
    Date of Patent: November 30, 2004
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Golberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Publication number: 20040202661
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Application
    Filed: December 5, 2003
    Publication date: October 14, 2004
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Golberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Crystal structure of the mouse apoptosis-inducing factor AIF and applications of such structural data to structure-based identification, screening, or design of AIF agonists or antagonists as well as AIF fragments, mutants or variants
    Publication number: 20040106119
    Abstract: Structural features of Apoptosis-inducing Factor (AIF), a flavoprotein that can stimulate a caspase-independent cell-death pathway. Structure-based screening, identification and design of molecules that modulate AIF functional activities, including apoptosis and redox activity. Molecules useful for modulating apoptosis or AIF redox activity obtained by these methods.
    Type: Application
    Filed: April 21, 2003
    Publication date: June 3, 2004
    Inventor: Pedro Alzari
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Publication number: 20020044935
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Application
    Filed: February 6, 2001
    Publication date: April 18, 2002
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie